Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics)

Editor-in-Chief:

Adrián LLerena, MD, Ph.D
Extremadura University
Hospital and Medical School
Badajoz, Extremadura
Spain

Back

Become EABM
Become Reviewer

Open Access Articles

Association between Paraoxonase 1(PON1) Gene Polymorphisms and PON1 Enzyme Activity in Indian Patients with Coronary Artery Disease (CAD) open Access plus

Volume: 16   Issue: 3
Pp: 219-229
Renuka Munshi*, Falguni Panchal, Ajay Chaurasia and Girish Rajadhyaksha
DOI:10.2174/1875692117666181227112119

Computational Studies of Molecular Targets Regarding the Adverse Effects of Isoniazid Drug for Tuberculosis open Access plus

Volume: 16   Issue: 3
Pp: 210-218
Nachimuthu Mohanasundaram and Talluri Sekhar*
DOI:10.2174/1875692116666181108145230

Molecular Mechanism of Metformin Associated Lactic Acidosis (MALA)- an In Silico Exploration open Access plus

Volume: 16   Issue: 3
Pp: 199-209
Siddiqur Rahman, Tamim Ahsan, Riajul Hossain, Tasnim Ahmed and Abu Ashfaqur Sajib*
DOI:10.2174/1875692117666181207121639

Metabolomics-based Approach to Pharmacotherapy Personalization: Advantages and Limitations open Access plus

Volume: 16   Issue: 3
Pp: 192-198
Dmitry L. Maslov*, Elena E. Balashova, Oxana P. Trifonova and Petr G. Lokhov
DOI:10.2174/1875692116666181008144905

Drug Abuse Treatment through Gene Manipulation Using Nanomedicine open Access plus

Volume: 16   Issue: 3
Pp: 182-191
Firoozeh Alavian*
DOI:10.2174/1875692117666181207120751

Oxidative Stress as a Key Signaling Pathway in Placental Angiogenesis Changes in Preeclampsia: Updates in Pathogenesis, Novel Biomarkers and Therapeutics open Access plus

Volume: 16   Issue: 3
Pp: 167-181
Enoch Odame Anto, Peter Roberts, Cornelius Archer Turpin and Wei Wang*
DOI:10.2174/1875692117666181207120011

Individualized Cancer Therapy, Future Approaches open Access plus

Volume: 16   Issue: 2
Pp: 156-163
Da-Yong Lu*, Ting-Ren Lu, Bin Xu, Jin-Yu Che, Ying Shen and Nagendra Sastry Yarla
DOI:10.2174/1875692116666180821095434

A Prospective Observational Pilot Study of Adverse Drug Reactions in Patients Admitted in the Geriatric Ward of a Tertiary Hospital in North India open Access plus

Volume: 16   Issue: 2
Pp: 147-155
Upinder Kaur, Sankha Shubhra Chakrabarti*, Bhanupriya Singh and Indrajeet Singh Gambhir
DOI:10.2174/1875692116666180830124924

Evaluation of Estrogen Receptor α and ß Genes Expression in Normal and Neoplastic Mammary Gland in Dogs by Real-time PCR open Access plus

Volume: 16   Issue: 2
Pp: 140-146
M.R. Nassiri*, S.A. Hosseini, S. Ghovvati and M. Zabetian
DOI:10.2174/1875692116666180907100151

Current Clinical Application and Response Prediction Biomarkers of PARP Inhibitors open Access plus

Volume: 16   Issue: 2
Pp: 108-117
Wei-Hua Shao, Lei-Yun Wang and Ji-Ye Yin*
DOI:10.2174/1875692116666180821152601

Dynamic Biomarkers of Response to Antiangiogenic Therapies in Colorectal Cancer: A Review open Access plus

Volume: 15   Issue: 2
Pp: 81-85
Jesus Rodriguez-Pascual* and Antonio Cubillo
DOI:10.2174/1875692115666170815161754

Beneficial Effects of Dietary Supplements Against Mitochondrial Dysfunction and Apoptosis in Neurodegenerative Diseases open Access plus

Volume: 13   Issue: 2
Pp: 93-98
Mohammed Akbar, Musthafa M. Essa, Byoung-Joon Song and Mohammed A.S. Khan
DOI:10.2174/1875692114999160502130439

Systematic 3D Screening of Amino Acid Mutations in Pharmacogenes open Access plus

Volume: 12   Issue: 4
Pp: 209-226
Thanawadee Preeprem and Greg Gibson
DOI:10.2174/1875692113666150408222109

Ethical, Political and Societal Implications of the Open Access Journal Movement in the Era of Economic Crisis, with Emphasis on Public Health Pharmacogenomics open Access plus

Volume: 11   Issue: 4
Pp: 312-315
Nicola L. Bragazzi
DOI:10.2174/1875692111666131126234122

Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga open Access plus

Volume: 11   Issue: 2
Pp: 98-109
Derek So and Yann Joly
DOI:10.2174/1875692111311020003

Situating Nutri-Ethics at the Junction of Nutrigenomics and Nutriproteomics in Postgenomics Medicine open Access plus

Volume: 11   Issue: 2
Pp: 162-166
Nicola L. Bragazzi
DOI:10.2174/1875692111311020008

Rethinking Pharmacogenomics Education Beyond Health Professionals: Addressing the “Know-Do” Gap Across the Personalized Medicine Innovation Ecosystem open Access plus

Volume: 10   Issue: 4
Pp: 277-287
Y. W. Francis Lam
DOI:10.2174/187569212803901828

Teaching Pharmacogenetics in Low and Middle Income Countries (LMICs): An Empirical Study of the Lessons Learned open Access plus

Volume: 10   Issue: 3
Pp: 217-225
Fatima Ghaddar, Karim Saba and Nathalie K. Zgheib
DOI:10.2174/187569212802510012

Modulating Blood-Brain Barrier Permeability and Treatment-Resistant Psychiatric Illness: Is Pituitary Neuroimaging a New Frontier? open Access plus

Volume: 10   Issue: 3
Pp: 182-184
Christopher Reist, Jogeshwar Mukherjee and Joseph C. Wu
DOI:10.2174/187569212802509979

A Broader Perspective on Personalized Medicine: Lessons from Discourse Analysis and Knowledge Translation open Access plus

Volume: 10   Issue: 3
Pp: 179-181
Bev J. Holmes
DOI:10.2174/187569212802510003

Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine open Access plus

Volume: 9   Issue: 4
Pp: 299-322
Murielle Bochud, Michel Burnier and Idris Guessous
DOI:10.2174/187569211798377135

The Genetic Privacy Carousel: A Discourse on Proposed Genetic Privacy Bills and the Co-Evolution of Law and Science open Access plus

Volume: 9   Issue: 4
Pp: 252-263
Edward S. Dove
DOI:10.2174/187569211798377207

Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation open Access plus

Volume: 9   Issue: 3
Pp: 191-207
Louise Warnich, Britt I. Drogemoller, Michael S. Pepper, Collet Dandara and Galen E.B. Wright
DOI:10.2174/187569211796957575

Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines open Access plus

Volume: 9   Issue: 3
Pp: 184-190
Anatasha Crawford and Rita Nahta
DOI:10.2174/187569211796957584

Personalizing HER2-Targeted Therapy in Metastatic Breast Cancer Beyond HER2 Status: What We Have Learned from Clinical Specimens open Access plus

Volume: 7   Issue: 4
Pp: 263-274
R. Nahta, S. Shabaya, T. Ozbay and D. L. Rowe
DOI:10.2174/187569209790112337

Interview: Dr. Muin J. Khoury Discusses the Future of Public Health Genomics and why it Matters for Personalized Medicine and Global Health open Access plus

Volume: 7   Issue: 3
Pp: 158-163
Muin J. Khoury
DOI:10.2174/1875692110907030158

Functional Crosstalk Between β2-adrenoreceptor and Muscarinic Acetylcholine Receptor: Implications for Gene-Gene Interactions and Bronchodilatory Responses in Patients with Asthma and COPD open Access plus

Volume: 6   Issue: 4
Pp: 302-319
Takahiro Yoshikawa and Hiroshi Kanazawa
DOI:10.2174/187569208786733857

Do Estrogen Receptor β Polymorphisms Play A Role in the Pharmacogenetics of Estrogen Signaling? open Access plus

Volume: 6   Issue: 4
Pp: 239-259
Stephanie L. Nott, Yanfang Huang, Brian R. Fluharty, Anna M. Sokolov, Melinda Huang, Cathleen Cox and Mesut Muyan
DOI:10.2174/187569208786733820

Personalized Medicine, Bioethics and Social Responsibilities: Re-thinking the Pharmaceutical Industry to Remedy Inequities in Patient Care and International Health open Access plus

Volume: 6   Issue: 2
Pp: 108-120
Catherine Olivier, Bryn Williams-Jones, Beatrice Godard, Barbara Mikalson and Vural Ozdemir
DOI:10.2174/1875692110806020108